Central venous line insertion and its maintenance in micro preemies carry significant risk for serious complications considering their small size and the skill involved in insertion. Hence, for uninterrupted and safe administration of essential medications and nutrition in these extreme preemies, we have come up with a minimally invasive technique of central venous access (MICVA technique) using peripherally inserted central catheter (PICC) of smaller caliber. We report a case series of 7 micro preemies who had difficult peripheral venous access because of their long stay in the neonatal intensive care unit (NICU) due to their extreme prematurity. We used a minimally invasive technique wherein under ultrasound guidance, the femoral vein was directly punctured with the splitting introducer needle (24G) available in a PICC set (28G/1Fr catheter with a stylet and splitting needle, Premicath, Vygon) (a size appropriate for micro preemies). Once the blood return was seen, the catheter was advanced up to the premeasured length, and then, the introducer needle was slowly withdrawn out and split. The catheter tip position was then checked with X-ray before starting any infusions. Throughout the procedure, non-pharmacological developmentally supportive care measures were followed. We did not encounter any serious complications except for a small hematoma which was encountered in 2 (28.6%) cases. The Premature Infant Pain Scale (PIPS) score measured for this minimally invasive technique was < 8 for all neonates. In our case series, using this technique (MICVA), we did not concur any serious complications. Local application of 2.5% Prilox cream with 25% oral dextrose and other non-pharmacological measures such as facilitated tuck, swaddling, nesting, and positioning significantly reduced pain and stress during the procedure. We recommend that this technique would be a safe approach in hemodynamically unstable neonates or in difficult venous access scenarios in extreme preterms. Invasive ventilatory support and use of benzodiazepines or opioids can be safely avoided with this technique.
Introduction
Having a secure central venous access has been a challenge for the neonatologists in case of extreme preemies, especially when all the peripheral venous accesses are exhausted. Prolonged central venous access plays a pivotal role in increasing the survival of these babies [1] . Umbilical venous catheter is used for nutrition and fluid management in the initial week after birth. Peripherally inserted central catheters (PICC) replace them in coming weeks. The usual sites for the insertion of PICC catheters are the basilic vein, cephalic vein, saphenous vein, and rarely brachial or axillary vein [2] .
Placement of a central venous catheter might be required if administration of parenteral nutrition, hypertonic fluids, inotropes, and antibiotics was planned in case of necrotizing enterocolitis, sepsis with hemodynamically instability, hypoglycemia, or post-surgery.
During their prolonged stay in the neonatal intensive care unit (NICU), PICC insertion at their usual sites may not be possible because they might have been either punctured or used earlier. Next option is to insert a central venous catheter in the internal jugular vein or femoral vein [3] . Central venous access is usually done by a trained pediatric surgeon or anesthetist in these preemies.
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In central venous access, an introducer needle is advanced with negative pressure until venous blood is aspirated. Then, the guidewire is threaded through the introducer needle hub, and while still holding the guidewire in place, the introducer needle is removed. Next, with the scalpel tip, a small stab in the skin is made against the wire just large enough to accommodate the dilator and eventually the central venous catheter. The dilator is inserted in a twisting motion and the central venous line (CVL) is advanced over the guidewire. Once the CVL is in place, the guidewire is removed.
In small neonates < 800 g, this technique carries serious complications such as bleeding, large hematoma, vessel laceration or dissection, hemopneumothorax, arterial puncture, injury to the phrenic nerve, venous thrombosis, and air embolism [4] [5] [6] . This technique frequently needs elective intubation and opioids for the procedure to be done optimally. This may also lead to autonomic and hemodynamic instability in these micro preemies. Further appropriate sizes of CVL catheters are not available for extreme preemies.
Case Series
We hereby report a case series of 7 micro preemies with used up peripheral venous accesses requiring central venous access due to their prolonged stay and critical illness. Out of 7 micro preemies, 3 (42.9%) were males and 4 (57.1%) were females. Their median gestational age and weight were 26 weeks and 650 g, respectively. The median age of insertion of the catheter was 26 days. Indications for central venous catheter (CVC) line insertion were necrotizing enterocolitis (NEC) in 2 (28.6%) cases, chronic lung disease in 1 (14.3%) case, inborn error of metabolism (IEM) in 1 (14.3%) case, severe sepsis in 2 (28.6%) cases, and post-operative in 1 (14.2%) case. Catheter was inserted on the right side in 5 (71.4%) cases and on the left side in 2 (28.6%) cases. In 5 cases (71.4%), insertion was done in the 1st attempt, and in 2 cases (28.6%), insertion was successful in the 2nd attempt. The mean duration of insertion was 9 min (range [6] [7] [8] [9] [10] [11] [12] [13] [14] .
The length of the catheter to be inserted was measured from the insertion site to the umbilicus and up to the xiphoid process. Informed consent was taken before the procedure. Prilox cream (lidocaine 2.5% + prilocaine 2.5%) with an occlusive patch was applied 45 min before the procedure on the site planned for cannulation [7] . A total of 25% oral dextrose (0.05 ml) was given 2 min before the procedure and was given in increments throughout the procedure up to 0.2 ml [8, 9] . All noxious stimuli such as excessive sound, light, and handling were avoided [10] .
After routine aseptic precautions, under ultrasound guidance with a 13-6 MHz Linear SonoSite M-Turbo probe, a 24G splitting introducer needle from a PICC kit (28G/1Fr catheter with a stylet and splitting needle, Premicath, Vygon) was inserted into the femoral vein, and when the blood return is seen, the introducer was advanced approximately 0.2-0.3 cm to make sure the needle was in the vein. The color, speed of blood flow, and pulsation of blood were observed to detect any inadvertent femoral arterial cannulation. Using non-toothed forceps, the catheter was then threaded through the introducer needle in 0.5 to 1.0 cm increments to the premeasured length. The introducer needle is then slowly removed until it is outside the skin several centimeters by applying digital pressure over the vein and the needle. The needle was then split as per manufacturer's guidelines (Fig. 1) . The catheter was ensured if it was at the premeasured length and X-ray was taken to confirm the tip position. This technique does not require any dilation of the vein avoiding venous laceration, large hematoma (> 0.5 cm in diameter), and risk of thrombosis in these extreme preemies.
Overall, 2.5% Prilox cream application with 25% oral dextrose was given preprocedure in all neonates. Facilitated tucking, partial swaddling, nesting, and developmentally appropriate positioning were done in all neonates once the catheter is secured to decrease the pain and stress of the neonate. Pain scores were measured with the Premature Infant Pain Scale (PIPS) which is a validated pain assessment scale for preterm babies [11] .
Result
A small hematoma (diameter less than 0.5 cm) was encountered in 2 (28.6%) cases and arterial puncture in 1 (14.3%) case which were managed with local compression. There was no significant bleeding, hypotension, or any autonomic instability while insertion in any case. The PIPS score measured for this minimally invasive technique was < 8 for all neonates. All these neonates did not require mechanical ventilation or intravenous sedation or opioids for central venous line placement by this technique. 
Discussion
With advancing medical technology, survival of more and more micro preemies has become possible, but at the same time, securing safe venous access has become a major problem faced in NICU nowadays. The size of the central venous catheter is critical in extreme preemies. A catheter larger than 24 gauge will lead to difficulty in insertion. In addition, insertion of the guide wire involves the potential risk for great vessel or cardiac injuries.
Mactier et al. in their study showed very lowbirthweight neonates with surgically placed central venous lines have high incidence of infective and mechanical complications [12, 13] . Chen et al. in their study showed low immediate complication rates without serious sequelae with femoral venous catheterization in preterm infants weighing less than 1000 g using a 24G cannula [14] . The need for general anesthesia, sedation, or opioids for central line insertion carries significant risk in these neonates. Hong et al. reported that venous cutdown at bedside did not require general anesthesia as a safe procedure in this category [15] . Violet et al. used sevoflurane in neonates for CVC line insertion for procedural sedation [16] .
In our study, we have used a 28G cannula that is optimal for the micro preemies. This technique avoids guide wire insertion and the need for venous dilatation with subsequent laceration of the venous wall in these tiny babies. Non-pharmacological measures of pain relief were followed throughout the procedure. We have not used any intravenous sedatives or opioids for this procedure. The Premature Infant Pain Scale (PIPS) score measured for this minimally invasive technique ensures less stress and pain to the newborn.
This minimally invasive technique may be helpful for neonatologists in securing central venous access particularly in centers where a pediatric anesthetist or a surgeon is not available. Limitations of our study include small sample size, and so peri-procedural complications have to be interpreted with caution. Incidence of complications relies on the skill of the neonatal physician who performs the procedure. So generalizing results of a single center cannot be justified. Further larger randomized control studies are required to interpret possible complications.
Conclusion
Smaller vessel size and bigger catheter diameter sizes of available CVC increase the complications during insertion and maintenance in micro preemies. In our case series, using this technique (MICVA), we did not concur any serious complications. Local application of 2.5% Prilox cream with 25% oral dextrose before the procedure and other non-pharmacological measures such as facilitated tuck, swaddling, nesting, and positioning significantly reduced pain and stress during the procedure.
Hence, we recommend that this technique would be a safe approach in hemodynamically unstable neonates or in difficult venous access scenarios in extreme preterms. Invasive ventilatory support and use of benzodiazepines or opioids can be safely avoided.
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